HPV Vaccine Trials at ICMR: Latest Updates on Single-Dose Research
Thursday, 13 March 2025, 07:36
Ongoing HPV Vaccine Trials
The Department of Health Research has informed lawmakers that ICMR is conducting critical trials of a single-dose HPV vaccine. These trials involve three ICMR institutes where volunteers will be monitored for two years to assess the vaccine's efficacy and safety.
Importance for Public Health
- The single-dose HPV shot could revolutionize cervical cancer prevention.
- ICMR's commitment to timely research completion is crucial for public health improvement.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.